HCV RNA at 12 weeks after treatment can predict sustained virologic response in chronic hepatitis C patients treated with pegylated interferon and ribavirin

被引：0
|
作者：
Yang, Sun
Lee, Joon Hyoek
Gwak, Geum-Youn
Choi, Moon Seok
Koh, Kwang Cheol
Paik, Seung Woon
Yoo, Byung Chul
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A830 / A830
页数：1
相关论文
共 50 条
  • [21] A panel of gene expression biomarkers predicting sustained virologic response (SVR) in chronic hepatitis C patients (CH-C) treated with pegylated interferon alpha and ribavirin
    Younossi, Z. M.
    Baranova, A.
    Stepanova, M.
    Afendy, A.
    Wheeler, A.
    Hossain, N.
    Bakshi, A.
    Santini, C. D.
    Sigua, C. L.
    Chan, J.
    Iverson, A. A.
    Chang, S. P.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S286 - S286
  • [22] Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
    Garib, Junia Rios
    Garcia, Guilherme Freire
    Teixeira, Rosangela
    Lima e Silva, Francisco das Chagas
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (08) : 625 - 631
  • [23] PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS
    Zeuzem, S.
    Demasi, R.
    Foster, G. R.
    Buti, M.
    Baldini, A.
    Luo, D.
    Witek, J.
    Rizzetto, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S452 - S452
  • [24] Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin
    Jablonowska, Elzieta
    Piekarska, Anna
    Koslinska-Berkan, Ewa
    Omulecka, Aleksandra
    Szymanska, Bozena
    Wojcik, Kamila
    ACTA BIOCHIMICA POLONICA, 2012, 59 (03) : 333 - 337
  • [25] ASSESSMENT OF SERUM HCV RNA AT WEEK 12 POST-TREATMENT 15 AS RELEVANT AS WEEK 24 TO PREDICT SVR IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Martinot-Peignoux, Michelle
    Christianne, Stern
    Pierre, Rlpault Marie
    Leclere, Laurence
    Boyer, Nathalie
    Asselah, Tarik
    Marcellin, Patrick
    HEPATOLOGY, 2009, 50 (04) : 359A - 359A
  • [26] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621
  • [27] Gamma Glutamyl Transferase Level as A Predictor of Sustained Virologic Response in Patients Treated With Interferon and Ribavirin for Chronic Hepatitis C Infection
    Pradhan, Srijan Man
    Rathore, Rabia
    Butt, Nasir Farooq
    Latif, Hina
    Azeem, Mariam
    Iqbal, Adil
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (04): : 859 - 862
  • [28] Twelve Weeks Posttreatment Follow-up Is as Relevant as 24 Weeks to Determine the Sustained Virologic Response in Patients with Hepatitis C Virus Receiving Pegylated Interferon and Ribavirin
    Martinot-Peignoux, Michelle
    Stern, Christiane
    Maylin, Sarah
    Ripault, Marie-Pierre
    Boyer, Nathalie
    Leclere, Laurence
    Castelnau, Corinne
    Giuily, Nathalie
    El Ray, Ahmed
    Cardoso, Ana-Carolina
    Moucari, Rami
    Asselah, Tank
    Marcellin, Patrick
    HEPATOLOGY, 2010, 51 (04) : 1122 - 1126
  • [29] Hepatitis C Virus Late Relapse after Sustained Virologic Response from Interferon and Ribavirin Treatment as Confirmed by RNA Sequencing
    Lu, Yidan
    Andonov, Anton
    Wong, David K. H.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (01) : 367 - 369
  • [30] Serum proteome profile to predict virological response in patients with chronic hepatitis C treated by pegylated interferon plus ribavirin
    Paradis, V
    Asselah, T
    Dargere, D
    Ripault, MP
    Martinot, M
    Boyer, N
    Valla, D
    Marcellin, P
    Bedossa, P
    HEPATOLOGY, 2005, 42 (04) : 444A - 444A
12345